Connection

Co-Authors

This is a "connection" page, showing publications co-authored by SUSAN DENFIELD and DEBRA KEARNEY.
Connection Strength

1.138
  1. The Many Faces of Arrhythmogenic Cardiomyopathy: An Overview. Appl Clin Genet. 2023; 16:181-203.
    View in: PubMed
    Score: 0.231
  2. Atypical infiltrates on endomyocardial biopsy are associated with adverse outcomes in pediatric heart transplantation. J Heart Lung Transplant. 2023 12; 42(12):1743-1752.
    View in: PubMed
    Score: 0.226
  3. Arrhythmogenic cardiomyopathy is under-recognized in end-stage pediatric heart failure: A 36-year single-center experience. Pediatr Transplant. 2023 03; 27(2):e14442.
    View in: PubMed
    Score: 0.216
  4. The presentation and diagnosis of coronary allograft vasculopathy in pediatric heart transplant recipients. Congenit Heart Dis. 2012 Jul-Aug; 7(4):302-11.
    View in: PubMed
    Score: 0.104
  5. Long-term follow-up of arrhythmias in pediatric orthotopic heart transplant recipients: incidence and correlation with rejection. J Heart Lung Transplant. 2003 Aug; 22(8):889-93.
    View in: PubMed
    Score: 0.057
  6. LMOD2-related dilated cardiomyopathy presenting in late infancy. Am J Med Genet A. 2022 06; 188(6):1858-1862.
    View in: PubMed
    Score: 0.051
  7. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation. 2000 Aug 22; 102(8):876-82.
    View in: PubMed
    Score: 0.046
  8. A 14-year-old in heart failure with multiple cardiomyopathy variants illustrates a role for signal-to-noise analysis in gene test re-interpretation. Clin Case Rep. 2019 Jan; 7(1):211-217.
    View in: PubMed
    Score: 0.041
  9. Update on pediatric heart transplantation. Long-term complications. Tex Heart Inst J. 1997; 24(4):260-8.
    View in: PubMed
    Score: 0.036
  10. Developmental differences in canine cardiac surgical scars. Am Heart J. 1993 Aug; 126(2):382-9.
    View in: PubMed
    Score: 0.028
  11. Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. J Am Coll Cardiol. 2010 Aug 10; 56(7):582-92.
    View in: PubMed
    Score: 0.023
  12. Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients. J Heart Lung Transplant. 2010 Jul; 29(7):739-46.
    View in: PubMed
    Score: 0.023
  13. Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children. Circulation. 2005 Sep 13; 112(11):1612-7.
    View in: PubMed
    Score: 0.016
  14. Usefulness of routine surveillance biopsies in children more than one year after orthotopic heart transplantation. Am J Cardiol. 2001 Mar 01; 87(5):667-8, A11.
    View in: PubMed
    Score: 0.012
  15. Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients. Transplantation. 1998 Jun 15; 65(11):1470-6.
    View in: PubMed
    Score: 0.010
  16. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation. 1997 Nov 18; 96(10):3549-54.
    View in: PubMed
    Score: 0.010
  17. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction. J Heart Lung Transplant. 1996 Feb; 15(2):111-23.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.